Drug development

3-day Course

About the course

Drug development projects are often initiated by identifying treatment for a disease. The project usually contains a deep knowledge of the disease and the biological mechanism.

However, in order to develop a drug for the disease, a broad knowledge of many different areas is required. This three-day course provides insights into all the parts that should be addressed to effectively target a drug project. This course primarily focuses on small molecules. The course is given in English.

The course is organized in cooperation with SwedenBIO.

Who should attend?

The course is aimed for those involved in drug development (eg in small and medium-sized companies), and needs a comprehensive picture of the complex development chain.

To get the most exchange of the course, it is an advantage to have a natural science background. This course’s main focus is on small molecules.

Learning objectives

During the course you will get insight into how to work in the different stages of development, what to think about and what pitfalls there are on the road.

Course outline

Day 1

Starting a development project/TPP
Regulatory strategy
Medicinal chemistry
Patent/IP
Assay development
In Vitro-pharmacology
ADME and drug metabolism
Translational Science/biomarkers

Day 2

PK/PD
PD studies/In Vivo- Pharmacology
Non clinical safety studies
Preclinical formulation
Preclinical development and CMC
Manufacturing of active pharmaceutical ingredient
Analytical chemistry in drug development
Quality (QA/QC)
Pharmaceutical development incl. manufacturing

Day 3

Clinical trials
Medical Products Agency
Health economics and reimbursement
Business Development
Financing
Licensing Strategies among big pharma
Pharmacovigilance
Market, phase IV & post reg. phase

Lecturer

All lecturers have experience from drug development and most have worked with or in small drug development companies.